Table 1.
Virus | Herpes Simplex Virus | Adenovirus | Vaccinia Virus | Parvovirus |
---|---|---|---|---|
Family | Herpesviridae | Adenoviridae | Poxviridae | Parvoviridae |
Genome | dsDNA | dsDNA | dsDNA | ssDNA |
Method of entry | HVEM, nectin 1 or 2 | CAR | Macropinocytosis | Sialic acid residues |
Replication site | Nucleus | Nucleus | Cytoplasm | Nucleus |
Phase of clinical trials | I–III | I–III | I–III | I–II |
Disease types for clinical trials | Melanoma, H and N cancer, pancreatic cancer, GBM, breast cancer, HCC | H and N cancer, pancreatic cancer, GBM, breast cancer, prostate cancer, ovarian cancer, CRC, bladder cancer | H and N cancer, melanoma, lung cancer, breast cancer, HCC, CRC | GBM |
Note: dsDNA, double-stranded DNA; ssDNA, single-stranded DNA; HVEM, herpesvirus entry mediator; CAR, coxsackie-adenovirus receptor; H and N, head and neck; GBM, glioblastoma multiforme; HCC, hepatocellular carcinoma; CRC, colorectal cancer.